ProteinQure raises $4 mln in Felicis Ventures-led seed round
ProteinQure, a Toronto-based software platform for computational protein drug discovery, has raised about $4 million in a seed-stage financing. U.S. venture capital firm Felicis Ventures led the round. It was joined by 8VC, Golden Ventures, Inovia Capital, Global Founders Capital and angel investor Tom Williams. Launched two years ago by CEO Lucas Siow, CTO Tomas Babej, Head of R&D Mark Fingerhuth and CSO Chris Ing, ProteinQure uses molecular simulations, machine learning and quantum computing to solve drug design challenges and deliver new protein-based therapeutics. The company will use the funds raised for new hires and to expand industry partnerships.
29 July 2019•3 mins read
